Renal histopathological lesions after liver transplantation: What can we find besides calcineurin inhibitor-induced nephrotoxicity?

Table 2 Correlation of risk factors for kidney disease, immunosuppression, and histological alterations in patients with kidney biopsy after liver transplantation

Patient	Gender	Age (years)	Interval between liver transplantation and kidney biopsy (years)	Primary etiology of liver disease	HTN	DM	HCC	Scr (umol/L)	BUN (mmol/L)	eGFR (ml/min/1.73m²)	Proteinuria (g/24 h)	UACR (mg/g)	Urine ɑ1-microglobulin (mg/L)	Urine β2-microglobulin (mg/L)	Serum albumin (g/L)	UA (umol/L)	HBA1C (%)
1	female	55	10.67	HBV	N	N	N	149	9.3	32	620.1	897.5	< 5.26	0.18	39	667.2	5.2
2	male	31	0.34	HBV	N	N	N	103	6	73	3242.4	1568.8	15.20	< 0.17	26.6	475	5.1
3	male	59	1.16	HBV	Y	Y	Y	205	12	29	4480.9	4868.5	45.70	0.71	29	326	4.5
4	male	55	0.87	HBV	Y	N	N	112	6.5	59	245.0	25.6	25.10	3.02	46.1	427	4.9
5	male	55	10.24	HBV	N	Y	N	142	5.6	45	5824.8	2528.1	34.80	13.10	29.7	379	6.4
6	Male	54	0.67	HBV	Y	Y	Y	164	14.4	37	165.1	29.1	40.30	0.40	40.2	441	4.9
7	Male	62	5.17	HBV	Y	N	Y	95	7	49	3868.8	2649.6	30.10	2.23	27.4	296	6.2
8	Male	53	3.79	HBV	Y	N	Y	140	6.3	46	4500	1375.1	19.00	1.96	33.7	525	5.2
9	Male	52	2.64	HBV	Y	Y	Y	232	13.1	26	1065.5	2391.5	42.60	2.48	30.8	338	5.3
10	Male	72	0.23	Schistosomiasis	Y	N	Y	86	4.8	81	2761.2	2244.7	34.2	15.3	40.7	314	6.0
11	Male	57	134.73	PSC	N	N	N	125.00	9.70	55.00	126.4	106.0	20.90	0.28	36.50	465.00	4.80
12	Male	63	86.10	HBV	Y	N	Y	106.00	9.20	64.00	11183.7	4013.5	27.70	5.39	29.00	407.00	6.80
13	Male	75	39.27	HBV	Y	N	Y	99.00	9.90	48.00	3015.00	2656.7	18.20	0.00	31.00	408.00	4.90
14	Male	53	20.73	HBV	Y	Y	N	97.00	6.30	70.00	6360.90	2998.0	51.70	1.63	34.70	444.00	5.40

HTN, hypertension; DM, diabetes mellitus; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; BUN, blood urea nitrogen; UACR, urine albumin/creatinine rate; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; PSC, primary sclerosing cholangitis; Y, yes; N, no

ISSN: 1471-2369